期刊文献+

Losatan压抑大鼠压力超负荷高血压和心肌肥大的实验研究 被引量:2

Experimental Study on Rats' Pressure Overload Hypertension and Cardiac Hypertrophy Inhibited by Losatan
暂未订购
导出
摘要 利用腹主动脉缩窄性高血压大鼠模型 ,以平均动脉压 (MAP)和左心室重 /体重比值(LVW /BW )作为指标 ,观察血管紧张素Ⅱ (AngⅡ )受体拮抗剂芦沙坦 (Losatan ,Los)在压力超负荷高血压和心肌肥大反应过程中的作用 .结果发现 :1.腹主动脉缩窄 (COA)大鼠术后第 1、4、8、12周MAP明显增高 ,并呈时间依赖性 ;COA组大鼠与假手术 (Sham)组大鼠各时间点的MAP比较均显著升高 .2 .COA大鼠术后第 1、4、8、12周LVW /BW明显增高 ,并呈时间依赖性 ;COA组大鼠与Sham组大鼠各时间点的LVW/BW比较均显著升高 .3.Los明显阻断COA大鼠MAP和LVW /BW的增高效应 ,与单纯COA组大鼠相比有极显著性差异 ;但是 ,Los对Sham组大鼠的MAP和LVW/BW无明显影响 .以上结果表明 :腹主动脉缩窄可作为高血压和心肌肥大反应的动物模型 ;AngⅡ参与诱发压力超负荷高血压和心肌肥大反应的发生 . Using the model of rat with the hypertension of abdominal aorta coarctation(COA),and taking the mean arterial pressure(MAP) and the ratio of left ventricular weigh to body weight(LVW/BW) as an index,the authors observed the effects of Losatan(LOS)-angiotensin Ⅱ 1 st type receptor inhibitor-on the rats' pressure overload hypertension and cardiac hypertrophy. It was found that:the MAP and LVW/BW significantly increased at the 1 st,4 th,8 th,and 12 th weeks after rats' COA operation,and had a relevance with time; while compared with the rats' MAP and LVW/BW of Sham group,both the rats'MAP and LVW/BW in COA group obviously increased at every time unit.On the other hand,Los could obviously reduced COA rats' MAP and LVW/BW,but it didn't obviously affect on the rats' MAP and LVW/BW in Sham group.The above results showed that COA rats could be used as an animal model of hypertension and cardiac hypertrophy; and that Ang Ⅱ had participated in the reactive process of inducing the rats' pressure overload hypertension and cardiac hypertrophy.
出处 《海南大学学报(自然科学版)》 CAS 2001年第4期373-376,共4页 Natural Science Journal of Hainan University
基金 海南省自然科学基金资助项目 (30 0 18) 海南省卫生厅资助课题 琼卫 (2 0 0 0 - 78)
关键词 高血压 心肌肥大 血管紧张素Ⅱ Losatan 实验研究 AngⅡ hypertension cardiac hypertrophy angiotensinⅡ Losatan
  • 相关文献

参考文献7

  • 1[1]ZABLGOITIA M. Left ventricular mass and function in primary hypertension[J].Am J Hypertens, 1996,9:55s-59s.
  • 2[2]CROZIER I,IKRAM H,AWAN N,et al. Losartan in heart failure;hemodynamic effect and tolerability[J]. Circulation,1995,91:691-697.
  • 3[3]IZUMI Y, KIM S, ZHAN Y, et al. Important role of angiotensin Ⅱ-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats[J]. Hypertension,2000,36:511-516.
  • 4[4]BAKER K M,CHERIN M I,WIXON S K,et al. Renin angiotensin system involvement in pressure-overload cardiac hypertrophy in the rats[J]. Am J Physiol,1990,259:H324-H332.
  • 5[5]GOODFRIEND T L, ELLIOTT M E, CATT K J. Angiotensin receptors and their antagonists(Review)[J]. N Engl J Med,1996,334:1649-1654.
  • 6[6]JI H, LEUNG M, ZHANG Y, et al. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan[J].J Biol Chem,1994,269:16 533-16 536.
  • 7[7]PINTO Y M, PINTO-SIETSMA S J, PHILIPP T,et al. Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat[J]. Hypertension,2000,36:747-754.

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部